JAGLX vs. JGLTX
JAGLX (Janus Henderson Global Life Sciences Fund Class T) and JGLTX (Janus Henderson VIT Global Technology and Innovation Portfolio) are both mutual funds - JAGLX is a Health & Biotech Equities fund actively managed by Janus Henderson, while JGLTX is a Technology Equities fund managed by Janus Henderson. Over the past 10 years, JAGLX returned 10.94%/yr vs 24.75%/yr for JGLTX. A 0.65 correlation means they provide meaningful diversification when combined. JAGLX charges 0.92%/yr vs 0.72%/yr for JGLTX.
Performance
JAGLX vs. JGLTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JAGLX achieves a -2.55% return, which is significantly lower than JGLTX's 33.79% return. Over the past 10 years, JAGLX has underperformed JGLTX with an annualized return of 10.94%, while JGLTX has yielded a comparatively higher 24.75% annualized return.
JAGLX
- 1D
- 1.14%
- 1M
- -0.31%
- YTD
- -2.55%
- 6M
- -0.80%
- 1Y
- 26.04%
- 3Y*
- 11.36%
- 5Y*
- 8.05%
- 10Y*
- 10.94%
JGLTX
- 1D
- -0.99%
- 1M
- 16.01%
- YTD
- 33.79%
- 6M
- 33.57%
- 1Y
- 57.29%
- 3Y*
- 36.57%
- 5Y*
- 19.20%
- 10Y*
- 24.75%
JAGLX vs. JGLTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JAGLX Janus Henderson Global Life Sciences Fund Class T | -2.55% | 24.72% | 8.50% | 7.41% | -2.79% | 6.66% | 25.52% | 29.12% | 4.05% | 22.13% |
JGLTX Janus Henderson VIT Global Technology and Innovation Portfolio | 33.79% | 25.19% | 32.10% | 54.55% | -36.42% | 18.28% | 50.42% | 45.29% | 1.17% | 45.17% |
Correlation
The correlation between JAGLX and JGLTX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Jan 19, 2000 | 0.65 |
Over the past year, the correlation between JAGLX and JGLTX has dropped to 0.18 - well below their long-term average of 0.65, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JAGLX vs. JGLTX — Risk / Return Rank
JAGLX
JGLTX
JAGLX vs. JGLTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class T (JAGLX) and Janus Henderson VIT Global Technology and Innovation Portfolio (JGLTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JAGLX | JGLTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.10 | ||
| Sortino ratioReturn per unit of downside risk | -0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.47 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 2.73 | 3.74 | -1.01 |
| Martin ratioReturn relative to average drawdown | 8.66 | 12.80 | -4.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| JAGLX | JGLTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.78 | 2.88 | -1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.74 | -0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.63 | 1.01 | -0.38 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.36 | +0.22 |
Drawdowns
JAGLX vs. JGLTX - Drawdown Comparison
The maximum JAGLX drawdown since its inception was -58.96%, smaller than the maximum JGLTX drawdown of -81.78%. Use the drawdown chart below to compare losses from any high point for JAGLX and JGLTX.
Loading charts...
Drawdown Indicators
| JAGLX | JGLTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.96% | -81.78% | +22.82% |
Max Drawdown (1Y)Largest decline over 1 year | -9.71% | -15.81% | +6.10% |
Max Drawdown (3Y)Largest decline over 3 years | -17.41% | -23.72% | +6.31% |
Max Drawdown (5Y)Largest decline over 5 years | -22.25% | -45.18% | +22.93% |
Max Drawdown (10Y)Largest decline over 10 years | -27.38% | -45.18% | +17.80% |
Current DrawdownCurrent decline from peak | -5.47% | -0.99% | -4.48% |
Average DrawdownAverage peak-to-trough decline | -17.43% | -36.59% | +19.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.05% | 4.60% | -1.55% |
Volatility
JAGLX vs. JGLTX - Volatility Comparison
The current volatility for Janus Henderson Global Life Sciences Fund Class T (JAGLX) is 4.81%, while Janus Henderson VIT Global Technology and Innovation Portfolio (JGLTX) has a volatility of 6.92%. This indicates that JAGLX experiences smaller price fluctuations and is considered to be less risky than JGLTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JAGLX | JGLTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.81% | 6.92% | -2.11% |
Volatility (6M)Calculated over the trailing 6-month period | 10.89% | 16.88% | -5.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.86% | 20.52% | -5.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.92% | 26.09% | -10.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.41% | 24.49% | -7.08% |
JAGLX vs. JGLTX - Expense Ratio Comparison
JAGLX has a 0.92% expense ratio, which is higher than JGLTX's 0.72% expense ratio.
Dividends
JAGLX vs. JGLTX - Dividend Comparison
JAGLX's dividend yield for the trailing twelve months is around 4.65%, less than JGLTX's 6.71% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JAGLX Janus Henderson Global Life Sciences Fund Class T | 4.65% | 4.53% | 10.98% | 4.22% | 0.14% | 9.78% | 7.75% | 6.17% | 13.38% | 0.89% | 1.13% | 9.09% |
JGLTX Janus Henderson VIT Global Technology and Innovation Portfolio | 6.71% | 8.98% | 0.00% | 0.00% | 26.96% | 14.48% | 7.71% | 6.81% | 4.95% | 5.68% | 3.71% | 16.11% |
Frequently Asked Questions
JAGLX and JGLTX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JGLTX has higher volatility (6.92%) compared to JAGLX (4.81%). In terms of maximum drawdown, JAGLX dropped -58.96% vs JGLTX's -81.78%.
JGLTX currently has the higher Sharpe Ratio (2.88 vs 1.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JAGLX and JGLTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer